Switching to tirzepatide yields greater quality-of-life benefits than increasing the dulaglutide dose in patients with type 2 diabetes.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how research tools & consumables stocks fared in Q4, starting ...

From juicing demos to cloning vocals, AI music tools are creeping into the workflows of top producers, songwriters and ...

From the mouse to Apple Silicon, here are the ten audacious bets Apple made across 50 years — each greeted with ridicule by ...

FTSE Russell has launched the FTSE Asia Pacific Liquid Government Bond Index Series, a new benchmark suite designed to track liquid local currency government bonds across India, Indonesia, Malaysia, ...

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

Google is launching Lyria 3 Pro, an upgraded music model that generates longer, more customizable tracks, as it expands AI ...

Google is expanding the capabilities of its Lyria 3 music-making AI, enabling it to create tracks up to three minutes long ...

"Focused on moving from ideas to implementation," the Summit happens on April 14 at Solotech Studios in Hollywood. By Katie ...

Erik Woodring, Morgan Stanley, joins 'Closing Bell' to discuss Apple's stock strength, if AI is now a tailwind for Apple and much more.

Draft season kicks off in Blacksburg with Virginia Tech's Pro Day. The last batch of players from the Brent Pry era will test ...

Revenue of $51.7 million, an increase of $4.1 million or 9% compared to Q4 2024. Adjusted EBITDA 1 was $9.8 million compared to $10.1 million in Q4 2024, representing a 2% decrease. Net Debt to ...